AGN-151607-DP is named as a drug or biological intervention in 2 clinical trials in our USA trial register, 2 of which are recruiting. The lead sponsor is AbbVie. Registered phase: Phase 2. Conditions studied include Upper Limb Essential Tremor; Ventral Hernia.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT07226791 | Study of AGN-151607-DP to Assess Adverse Events and Change in Disease Activity in Adult Participants Undergoing Open Abdominal Ventral Hernia Repair (ClinicalTrials.gov ↗) Ventral Hernia |
Phase 2 | Recruiting |
| NCT07673107 | Study of AGN-151607-DP to Assess Adverse Events and Change in Disease Activity in Adult Participants With Upper Limb Essential Tremor (ClinicalTrials.gov ↗) Upper Limb Essential Tremor |
Phase 2 | Recruiting |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Upper Limb Essential Tremor | 1 |
| Ventral Hernia | 1 |
| Lead sponsor | Trials |
|---|---|
| AbbVie | 2 |
| Register | AGN-151607-DP trials |
|---|---|
| Clinical trials in USA | 2 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how AGN-151607-DP works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists AGN-151607-DP (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.